SOHM, Inc. (SHMN)

Market Cap	2.61M +63.0%
Revenue (ttm)	1.30M +115.2%
Net Income	-1.13M
EPS	-0.00
Shares Out	2.90B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	189,271
Average Volume	699,634
Open	0.0009
Previous Close	0.0009
Day's Range	0.0009 - 0.0009
52-Week Range	0.0005 - 0.0021
Beta	0.84
RSI	45.59
Earnings Date	n/a

About SOHM, Inc.

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 145
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHMN

Financial Performance

In 2012, SOHM, Inc.'s revenue was $1.30 million, a decrease of -3.27% compared to the previous year's $1.34 million. Losses were -$1.13 million, 106.1% more than in 2011.